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 2 
Abstract 26 
 27 
Tyramine and histamine, the most toxic biogenic amines (BA), are often 28 
found in high concentrations in certain foods. Prompted by the limited 29 
knowledge of BA toxicity, and increasing awareness of the risks associated 30 
with high intakes of dietary BA, the in vitro cytotoxicity of tyramine and 31 
histamine was investigated. Tyramine and histamine were toxic for HT29 32 
intestinal cell cultures at concentrations commonly found in BA-rich food, as 33 
determined by real-time cell analysis. Surprisingly, tyramine had a stronger 34 
and more rapid cytotoxic effect than histamine. Their mode of action was 35 
also different, while tyramine caused cell necrosis, histamine induced 36 
apoptosis. To avoid health risks, the BA content of foods should be reduced 37 
and legal limits established for tyramine. 38 
 39 
Keywords: Biogenic amines; Cytotoxicity; Food security; Histamine; 40 
Tyramine.  41 
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1. Introduction 46 
 47 
Biogenic amines (BA) are described as biologically active, low molecular 48 
weight organic bases that may accumulate in some foods owing to the 49 
undesirable microbial decarboxylation of certain amino acids (Linares, 50 
Martin, Ladero, Alvarez, & Fernandez, 2011; Naila, Flint, Fletcher, Bremer, & 51 
Meerdink, 2010). BA-producing microorganisms may be contaminants, but 52 
may also belong to groups that participate in food fermentation. In fact, 53 
certain bacterial species widely used in the dairy industry, and which enjoy 54 
‘generally regarded as safe’ (GRAS) status, have been typified as BA 55 
producers (Fernandez, Linares, & Alvarez, 2004; Ladero, Rattray, Mayo, 56 
Martin, Fernandez, & Alvarez, 2011; Linares, del Rio, Ladero, Redruello, 57 
Martin, Fernandez, et al., 2013). 58 
 59 
Foods likely to contain high BA concentrations are fish and fish products, 60 
along with fermented foods and beverages such as cheese and wine 61 
(European Food Safety Authority, 2011; Linares, del Rio, Ladero, Martinez, 62 
Fernandez, Martin, et al., 2012). The presence of BA in food is deemed a 63 
biological hazard by the Food and Agriculture Organization of the United 64 
Nations (FAO) (Food and Agriculture Organization of the United Nations, 65 
2014). Although cheese has been implicated in outbreaks of histamine 66 
poisoning, such incidents have long been associated with the ingestion of 67 
spoiled fish of the Scombroidae family (which gave rise to the term 68 
‘scombroid syndrome’) (Food and Drug Administration, 2001; Visciano, 69 
Schirone, Tofalo, & Suzzi, 2014). Typically, such poisoning is manifested as 70 
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allergic reactions, acute gastrointestinal distress, and perhaps neurological 71 
and cutaneous symptoms (Eastaugh & Shepherd, 1989). The term ‘cheese 72 
reaction’ was coined to refer to the symptoms - hypertension, migraine, 73 
headaches and other neurological problems - induced following the ingestion 74 
of cheese with high tyramine concentrations (Price & Smith, 1971; Shalaby, 75 
1996; Stratton, Hutkins, & Taylor, 1991). These problems can be particularly 76 
severe in people who are susceptible owing to a reduced capacity to detoxify 77 
BA in the gut (Ladero, Calles-Enriquez, Fernandez, & Alvarez, 2010; Spano, 78 
Russo, Lonvaud-Funel, Lucas, Alexandre, Grandvalet, et al., 2010). This 79 
capacity may vary due to genetic reasons, but risk factors such as 80 
gastrointestinal disease, the taking of certain medications and the intake of 81 
alcohol can reduce the activity of the detoxifying enzymes (Ladero, Calles-82 
Enriquez, Fernandez, & Alvarez, 2010). 83 
 84 
Although it is generally accepted that BAs should not be allowed to 85 
accumulate in food products, legislation in this respect is insufficient. It is 86 
very difficult to establish a uniform maximum limit for ingested BAs since their 87 
toxic effect depends on the type of BA in question, the presence of 88 
modulating compounds, and on the efficiency of each person’s detoxification 89 
system. The only BA for which maximum limits have been legally set by the 90 
European Food Safety Authority (EFSA) is histamine, and then only in 91 
scombroid-like fish (200 mg/kg) and fish products (400 mg/kg) (European 92 
Comission, 2005). The US Food and Drug Administration (FDA) suggested 93 
histamine concentrations in fish of over 500 mg/kg to be a danger to health 94 
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(Food and Drug Administration, 1996, 2001).  No further legislation exists 95 
anywhere to regulate histamine or the remaining BAs in any other food. 96 
 97 
Recently, the EFSA Panel on Biological Hazards (BIOHAZ) conducted a 98 
qualitative risk assessment for BAs in fermented foods, and concluded that 99 
our present knowledge of their toxicity was limited, and that further research 100 
was needed (European Food Safety Authority, 2011). Using real-time cell 101 
analysis (RTCA), the present work examines the in vitro toxicity of tyramine 102 
and histamine (the predominant BA in food) on human intestinal cells. The 103 
gastrointestinal mucosa, which is composed mainly of a monolayer of 104 
intestinal epithelial cells (IEC), represents the first point of contact with orally 105 
ingested BA. Cells belonging to the HT29 intestinal cell line, used as an in 106 
vitro model of IEC, were therefore exposed to different doses of tyramine and 107 
histamine and their cytotoxicity, including their capacity to induce necrosis 108 
and apoptosis, determined. The IC50, the ‘non-observed adverse effect level’ 109 
(NOAEL) and the ‘lowest observed adverse effect level’ (LOAEL) values 110 
were calculated for each BA. 111 
 112 
2. Material and Methods 113 
 114 
2.1. Cell line and growth conditions 115 
 116 
The intestinal cell line HT29 (ECACC 91072201), derived from a human 117 
colorectal adenocarcinoma, was purchased from the European Collection of 118 
Cell Cultures and used to create an in vitro model of the intestinal epithelium. 119 
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The HT29 cells were routinely cultured in McCoy's 5a medium supplemented 120 
with 10% heat-inactivated foetal bovine serum plus a mixture of antibiotics 121 
(50 µg/ml penicillin, 50 µg/ml streptomycin, 50 µg/ml gentamicin and 1.25 122 
µg/ml amphotericin B). All media and reagents were purchased from Sigma-123 
Aldrich (Madrid, Spain). All manipulations required for culturing, passaging 124 
(144 to 149 passages were performed) and maintenance of the cell line were 125 
undertaken in a 5% CO2 atmosphere at 37°C, in a SL Waterjacked CO2 126 
Incubator (Sheldon Mfg. Inc., Conrnelius, OR, USA), following standard 127 
procedures (Ruas-Madiedo, Medrano, Salazar, De Los Reyes-Gavilan, 128 
Perez, & Abraham, 2010). 129 
 130 
2.2. Real-time cell analysis 131 
 132 
The RTCA system is used to gather information on cell proliferation, 133 
migration and cytotoxicity via changes in cell morphology and adhesion 134 
(Atienzar, Tilmant, Gerets, Toussaint, Speeckaert, Hanon, et al., 2011). An 135 
xCelligence Real-Time Cell Analyzer (ACEA Bioscience Inc., Roche Applied 136 
Science, Germany) was used as previously described (Limame, Wouters, 137 
Pauwels, Fransen, Peeters, Lardon, et al., 2012) to detect any changes in 138 
the proliferation, migration adhesion or morphology of the HT29 intestinal 139 
cells following their treatment with different doses of tyramine [4-(2-140 
aminoethyl)phenol hydrochloride] (Acros Organics, Belgium) and histamine 141 
[2-(4-Imidazolyl)ethylamine dihydrochloride] (Sigma-Aldrich). Cells were 142 
seeded in 16-well E-Plates (Roche Applied Science) equipped with gold 143 
microelectrode sensors at the bottom.  These sensors generate an electric 144 
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field when a low voltage (<20 mV) is applied between the electrodes. Real-145 
time measurements of the electrical impedance (referred to as the cell index) 146 
across the interdigitated microelectrodes allows for dynamic monitoring. 147 
 148 
Briefly, HT29 cells were seeded at a density of 2 x 104 cells/well (for studies 149 
on proliferating cells) or 2 x 105 cells/well (for studies on confluent cells) in 150 
16-well E-Plates containing 100 µl of medium per well, and then incubated 151 
and monitored in a Heracell-240 Incubator (Thermo Electron LDD GmbH, 152 
Langenselbold, Germany) at 37°C and with a 5% CO2 atmosphere (Hidalgo-153 
Cantabrana, Kekkonen, de los Reyes-Gavilan, Salminen, Korpela, 154 
Gueimonde, et al., 2014). Stock solutions of tyramine and histamine were 155 
dissolved in water and adjusted to pH 6.8. Approximately 20 h after seeding, 156 
the cells were treated with one of 13 concentrations of tyramine (0 to 28.9 157 
mM) or histamine (0 to 129.7 mM). The cell index was monitored for 24 h for 158 
proliferation studies, and for 30 h for confluence studies, under the same 159 
conditions. The cell index was normalized to the time point just before the 160 
addition of the BA and set to 1. For each condition, measurements were 161 
performed in triplicate. 162 
 163 
Dose-response curves for tyramine and histamine were constructed using 164 
RTCA software, plotting the normalized cell index at 24 h of treatment 165 
against the log10 value of the corresponding BA concentration. Non-linear 166 
regression trend lines were fitted to sigmoid dose-response (variable slope) 167 
curves using SigmaPlot 13.0 software (Systat Software Inc., San Jose, CA, 168 
USA).  This software also provided the coefficient of determination (R2) as a 169 
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measurement of the goodness of fit of the data to the curves, as well as the 170 
Hill slope value, which indicates the steepness of the curve. 171 
 172 
The IC50 was defined as the concentration of BA required to achieve half of 173 
the strongest cytotoxic effect observed by RTCA. IC50 values for tyramine 174 
and histamine were calculated in proliferating cultures using RTCA software 175 
to construct a sigmoid dose response curve for arbitrary time points (8 h, 12 176 
h, 18 h and 24 h) of BA exposure.  177 
 178 
2.3. Fluorescence microscopy: nuclear DNA staining 179 
 180 
Cells were seeded at a density of 2 x 105 cells/well, and incubated in flat-181 
bottom microplates under identical conditions to those used in the RTCA 182 
studies. After 20 h of incubation the cells were treated with one of six 183 
different concentrations of tyramine (0 to 17.3 mM) or histamine (0 to 21.7 184 
mM). At 24 h post-treatment, the cells were washed with 0.1 M PBS pH 7.2, 185 
fixed with 3.7% paraformaldehyde for 15 min, permeabilised by immersion in 186 
absolute ethanol for 5 min, and then labelled with 4’6-diamino-2-phenylindole 187 
dihydrochloride (DAPI) (Thermo Fisher Scientific Inc., Madrid, Spain) by 188 
incubation for 5 min with the stain (DAPI 300 nM in 0.1 M PBS pH 7.2). Once 189 
the labelling solution was aspirated, the cells were rinsed three times in PBS, 190 
and each well of the microplate was viewed using a 3-colour LumaScope-191 
600 epifluorescence microscope (Etaluma Inc., CA, USA).  192 
 193 
2.4. Cell apoptosis  194 
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 195 
One of the most established hallmarks of apoptosis is DNA fragmentation 196 
(Saraste & Pulkki, 2000). The commercially available Cellular DNA 197 
Fragmentation ELISA Kit (Roche Applied Science) was used to measure 198 
apoptosis-associated DNA fragments in the cytoplasm. This assay is based 199 
on the quantitative “sandwich enzyme immunoassay” (ELISA) principle, and 200 
involves two mouse monoclonal antibodies directed against DNA and 5’-201 
bromo-2’-deoxyuridine (BrdU). Briefly, HT29 cells were seeded at 2 x 104 202 
cells/well in 96-well plates and incubated with BrdU for 20 h at 37°C in a 5% 203 
CO2 atmosphere. After this time, proliferating cells were exposed to the 204 
corresponding BA dose for 24 h. In parallel with the BA-treated samples, a 205 
negative control (untreated cells) was established to determine the 206 
spontaneous release of DNA fragments, and a positive control to estimate 207 
the incorporation of BrdU into the genomic DNA (cells treated with 1% Triton-208 
X100). Cells were collected after centrifugation at 250 g for 10 min and lysed 209 
with the incubation solution for 30 min at 25ºC. After further centrifugation at 210 
250 g for 10 min, the resulting supernatant was transferred to a microplate 211 
precoated with anti-DNA antibodies, followed by a standard ELISA assay to 212 
detect the BrdU-labelled DNA fragments. Finally, apoptosis-associated DNA 213 
was determined at 450 nm in a Benchmark Plus Microplate 214 
Spectrophotometer (Bio-Rad, Madrid, España). DNA fragmentation was 215 
expressed as the fold increase of the control values. 216 
 217 
2.5. Cell lysis assay 218 
 219 
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RTCA cell culture supernatants collected after 24 h of incubation with the 220 
corresponding dose of tyramine or histamine were tested for the presence of 221 
lactate dehydrogenase activity (LDH) using the LDH Assay Kit (Roche Applied 222 
Science), following the manufacturer´s instructions. The release of LDH into the 223 
medium is a marker of the cell membrane damage that occurs in necrosis.  224 
Negative (no lysing reagent) and positive controls (with lysis reagent) were run 225 
in parallel. 226 
 227 
2.6. Data and statistical analysis 228 
 229 
The results obtained in all experiments are expressed as the means ± 230 
standard deviation of three independent replicates. Statistical treatment 231 
involved ANOVA followed by Fisher’s multiple comparison test; this was 232 
performed using SigmaPlot software. Significance was set at p<0.05 233 
(indicated in figures with an asterisk). 234 
 235 
The NOAEL value was identified as the highest concentration of BA that 236 
caused no detectable adverse effect on the target cells. The LOAEL value 237 
was defined as the lowest concentration of BA that produced a detectable 238 
adverse effect.  239 
 240 
3. Results 241 
 242 
3.1. Dynamic cell responses of tyramine and histamine-treated intestinal cells  243 
 244 
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To determine whether tyramine and histamine treatments perturbed cell 245 
homeostasis and induced cytotoxic effects in the HT29 cells, dose-response 246 
curves were constructed in real time by the RTCA system. Approximately 20 247 
h after seeding, different concentrations of each BA were added and the cells 248 
monitored for 24 h (Fig. 1). It was found that the concentration of histamine 249 
and tyramine remained the same after the 24 hours (data not shown), 250 
suggesting insignificant amino oxidase activities in HT29 cell cultures. 251 
 252 
The curves showed that cells proliferated over the 20 h of culture before BA 253 
treatment. After this time, the curves for BA-untreated cultures showed 254 
continued proliferation. However, a drastic reduction in the normalized cell 255 
index was seen when the cells were exposed to increasing concentrations of 256 
tyramine (Fig. 1A) or histamine (Fig. 1B). Both BAs were associated with a 257 
dose-dependent cytotoxic effect. The effect of tyramine was very acute and 258 
rapid: the normalized cell index of proliferating cells treated with 259 
concentrations above 2.9 mM dropped within a few minutes. The cytotoxicity 260 
of the histamine was less severe than that of tyramine: cells treated with 5 261 
mM histamine showed no change in their proliferation curves. However, 262 
doses of 10.8 mM or higher were cytotoxic, although more moderately and 263 
less acutely so than observed for cytotoxic doses of tyramine. The cytotoxic 264 
effects of both BAs on confluent HT29 cells (data not shown) were similar to 265 
those seen on proliferating cells.  266 
 267 
Dose-response curves for tyramine and histamine were constructed 24 h 268 
after BA exposure (Fig. 2). Both that of tyramine (Fig. 2A) and histamine (Fig. 269 
 12 
2B) fitted a sigmoid curve with a R2 of 0.9823 and 0.9942 respectively. The 270 
Hill slope of the curve for tyramine (-3.14) was steeper than that for histamine 271 
(-1.44).  Thus, small increases in tyramine concentration had a greater toxic 272 
effect than small increases in histamine.  273 
 274 
The greater cytotoxicity of tyramine was confirmed when the IC50 values for 275 
each BA were compared at 8 h, 12 h, 18 h and 24 h (Table 1). For each time 276 
point, the RTCA data fitted a sigmoid dose-response curve with an R2 of 277 
>0.995 in all cases. The IC50 values showed both BAs to have a dose-278 
dependent cytotoxic effect on the HT29 cells (Table 1). Tyramine was 279 
approximately 10 times more toxic than histamine (IC50 of tyramine after 24 h 280 
of treatment 3.2 ± 0.04 mM, compared to 26.0 ± 1.2 mM for histamine).  281 
Thus, a 10-times lower concentration of tyramine than histamine is needed to 282 
achieve half of the latter’s strongest cytotoxic effect. The results also 283 
indicated that the cytotoxic effects of tyramine did not increase with 284 
incubation times beyond 18 h. In contrast, sensitivity to histamine increased 285 
over time.  286 
The NOAEL and LOAEL values for tyramine (Fig. 2A) were 1.8 mM and 2.2 mM 287 
respectively, and 3 mM and 4 mM respectively for histamine.  Thus, the cells 288 
showed a higher toxicological threshold for histamine.  289 
 290 
3.2. Fluorescence microscopy examination of tyramine- and histamine-291 
treated cell cultures 292 
 293 
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To visualize cytotoxic effects, cell cultures treated for 24 h with a range of 294 
tyramine or histamine concentrations were stained with DAPI and observed 295 
by fluorescence microscopy (Fig. 3). The number of cells decreased 296 
inversely with the concentration of both BAs, although the tyramine had a 297 
more severe effect. Tyramine doses above 2.9 mM had a more serious effect 298 
on the cells, indeed, at the two highest concentrations tested (11.5 mM and 299 
17.3 mM) very few cells were observed. The cytotoxicity of histamine began 300 
to become evident at higher concentrations (above 5 mM), but even beyond 301 
the maximum concentration of tyrosine used, the cytoxicity of histamine was 302 
less severe.  303 
 304 
The chromatin of the histamine-treated cells appeared more condensed - a 305 
characteristic of apoptosis - than the chromatin of the tyramine-treated cells 306 
(Fig. 3). This suggests that the mode of action of these BAs might be 307 
different. Further experiments to examine this were therefore performed. 308 
 309 
3.3. Apoptosis assays 310 
 311 
Intracellular DNA fragments typical of apoptotic cells were sought using the 312 
cellular DNA fragmentation assay. To ensure the meeting of the necessary 313 
cell death test conditions, endpoint times of 24 h were employed (the time 314 
needed by each BA to induced maximum cell damage). Intermediate doses - 315 
5.8 mM for tyramine and 16.3 mM for histamine – were used to ensure that 316 
cells would be damaged though not all would be killed. After BA-treatment of 317 
the BrdU-labelled cells, DNA fragments were extracted from the cytoplasm 318 
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and quantified. DNA-fragmentation detected in these cells was slightly 319 
increased (12.3%) in comparison with controls. In contrast, DNA 320 
fragmentation in the cells exposed to histamine increased by 43.9% (Fig. 4).  321 
This strongly suggests that histamine, much more so than tyramine, exerts 322 
an apoptotic effect. 323 
 324 
3.4. Assessment of cytolytic (necrotic) effect of tyramine and histamine  325 
 326 
The cytotoxic mode of action of tyramine and histamine was further assessed 327 
using the LDH assay. LDH is a cytosolic enzyme released into the medium 328 
after necrotic cell death. Based on the RTCA results, an LDH assay end-329 
point of 24 h was chosen. Assays were performed using the concentration 330 
range employed to construct the dose-response curves for tyramine and 331 
histamine. Figure 5 shows the percentage cytolysis induced by tyramine and 332 
histamine. Negligible LDH activity was detected in cell cultures exposed to 333 
histamine, except at the highest concentration tested (127.9 mM) in which 334 
cytolysis reached 45%. In contrast, a dose-dependent increase in LDH 335 
leakage was observed with tyramine, indicating that, unlike histamine, 336 
tyramine caused the necrosis of the HT29 cells.  337 
 338 
4. Discussion 339 
 340 
Dose-dependent toxic effects were observed both in proliferating and 341 
confluent cell cultures exposed to either tyramine or histamine.  However, 342 
tyramine was more cytotoxic than histamine at all time points, as indicated by 343 
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its lower IC50, NOAEL and LOAEL values compared to histamine. To our 344 
knowledge, this is the first report of IC50, NOAEL and LOAEL values for 345 
tyramine and histamine recorded for in vitro cultures of intestinal cell lines. 346 
Tyramine had an acute, rapid effect; the cell index dropped abruptly after 347 
treatment with 14.4 mM tyramine or higher doses, whereas a similar dose of 348 
histamine induced more moderate effects. An explanation for this can be 349 
found in the different mode of action of tyramine and histamine. LDH release 350 
from tyramine-exposed cells increased significantly, particularly at higher 351 
concentrations, indicating that this BA has a necrotic effect. In contrast, 352 
negligible cytolytic activity was detected in cultures exposed to histamine, 353 
suggesting that this BA causes cell death without affecting membrane 354 
stability. In addition, cells exposed to histamine showed significantly 355 
increased DNA fragmentation, strongly suggesting that the biochemical event 356 
behind the cell death induced by it is apoptosis rather than necrosis. 357 
Whereas necrosis is an unexpected, unordered and accidental form of cell 358 
death, apoptosis is a form of programmed cell death (Kanduc, Mittelman, 359 
Serpico, Sinigaglia, Sinha, Natale, et al., 2002). It has been reported that 360 
histamine is deeply involved in apoptosis triggering and progression 361 
(Toninello, Salvi, Pietrangeli, & Mondovi, 2004). Histamine is a key mediator 362 
in the development of allergic reactions, which evoke activation and 363 
degranulation of eosinophils and airway epithelial tissue injury; apoptosis is 364 
believed to be a major mechanism for the clearance of eosinophilic 365 
inflammation (Hasala, Giembycz, Janka-Junttila, Moilanen, & Kankaanranta, 366 
2008; Ling, Ngo, Nguyen, Thurmond, Edwards, Karlsson, et al., 2004). 367 
 368 
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The in vitro approach used in this work was shown to be a useful way of 369 
assessing the risk of toxicity after the consumption of food containing 370 
tyramine and histamine. These compounds are the most toxic of all BAs, and 371 
of particular importance with respect to food safety (European Food Safety 372 
Authority, 2011). However, in Europe legal limits have only ever been set for 373 
histamine, and then only in fish and fish products (European Comission, 374 
2005; established by the EFSA), and in the USA, the FDA has only 375 
established a guidance histamine concentration of 50 mg/kg for the 376 
consumption of scombroid or scombroid-like fish (Food and Drug 377 
Administration, 2001).  There is no legal limit at all for histamine in other 378 
foods, yet it can reach concentrations of 1850 mg/kg in cheese, 400 mg/kg in 379 
fermented sausages, and 758 mg/kg in sauces (European Food Safety 380 
Authority, 2011). These levels are much higher than the cytotoxicity threshold 381 
detected in the present work for histamine (4.0 mM, equivalent to 440.6 382 
mg/kg). This result supports previous assumptions that concentrations of 383 
histamine above 400 mg/kg are probably dangerous to health (Taylor, 1985). 384 
More recently, other authors have suggested histamine concentration of 500 385 
mg/kg in food to be hazardous to human health (Askar & Treptow, 1986; 386 
Rauscher-Gabernig, Grossgut, Bauer, & Paulsen, 2009; Shukla, Kim, & Kim, 387 
2011). It is generally assumed that histamine is the most toxic BA; however, 388 
to our knowledge there are no scientific data to substantiate it. The EFSA 389 
considers tyramine and histamine as the most toxic BA, but indicates that 390 
there is no available information to conduct quantitative risk assessment of 391 
BA (European Food Safety Authority, 2011). No legal limit for tyramine in 392 
food has ever been set anywhere, yet the present results indicate that this 393 
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BA is even more toxic than histamine. The recorded cytotoxicity threshold of 394 
2.2 mM is equivalent to 301.8 mg/kg, a concentration easily exceeded in 395 
cheese (in which concentrations of 2519 mg/kg have been detected 396 
(Redruello, Ladero, Cuesta, Alvarez-Buylla, Martin, Fernandez, et al., 2013), 397 
fermented sausages (up to 1740 mg/kg), fish and fish products (up to 634 398 
mg/kg) and fish sauces (up to 741 mg/kg) (European Food Safety Authority, 399 
2011). Concentrations below this threshold might also cause adverse 400 
reactions, although not so severe. However, people with less powerful BA-401 
detoxification systems caused by genetic deficiencies, gastrointestinal 402 
disease, mono- or diamine oxidase inhibitor medication, or who have 403 
ingested alcohol or other potentiating factors (Maintz & Novak, 2007), might 404 
be at greater risk.  405 
 406 
In summary, the present results reveal that unexpectedly, tyramine was more 407 
cytotoxic than histamine on an in vitro model of the human intestinal 408 
epithelium. Nevertheless, in both cases the concentrations found to be toxic 409 
are commonly reached in BA-rich foods. Thus, it might be advisable to 410 
establish measures aimed at reducing their concentrations to below the 411 
cytotoxic levels here determined. 412 
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6. Figure legends 542 
 543 
Figure 1. Real-time cell analysis of the effects of tyramine and histamine on 544 
HT29 cells.  Cells were seeded in a 16-well E-plate (20,000 cells/well) and 545 
after 20 h of growth were exposed to the indicated concentrations of tyramine 546 
(A) or histamine (B) or control medium (0 mM). The point of administration of 547 
tyramine or histamine is shown by vertical arrows on the graph. Changes in 548 
the normalized cell index were dynamically monitored every 15 min for 24 h.  549 
Data are the means of three replicates; vertical bars represent standard 550 
deviations.  551 
 552 
Figure 2. Dose-response curves for tyramine and histamine in HT29 553 
intestinal cells. Cell cultures were treated with a range of tyramine (A) or 554 
histamine (B) concentrations for 24 h. Data represent the means ± standard 555 
deviations of three experiments. The non-linear regression trend lines fitted a 556 
sigmoid dose-response curve (variable slope). An asterisk indicates the first 557 
significant difference with respect to the minimal dose of BA assayed (0.7 558 
and 0.2 mM for tyramine and histamine respectively) and represents the 559 
LOAEL concentration (*p<0.05). Numeric values for NOAEL, LOAEL, Hill 560 
slope and R2 are also indicated.  561 
  562 
Figure 3. Toxicity of tyramine and histamine on intestinal cells.  HT29 cells 563 
were grown in flat-bottomed microplates for 20 h, and then treated with 564 
increasing concentrations of (A) tyramine or (B) histamine for 24 h. They 565 
were then fixed, stained with DAPI, and viewed with an epifluorescence 566 
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microscope. Apoptotic cells are marked with white arrows. 567 
 568 
Figure 4. Apoptotic DNA-fragmentation induced by tyramine and histamine 569 
in HT29 intestinal cells. BrdU-labelled DNA fragments released from the 570 
nucleus to the cytoplasm due to apoptosis were quantified in HT29 cells 571 
exposed to 5.8 mM of tyramine or 16.3 mM histamine for 24 h. The 572 
percentage of DNA fragmentation was calculated as follows: 100 X [(DNA 573 
fragmentation of treated samples – DNA fragmentation of negative control) / 574 
(DNA fragmentation of positive control – DNA fragmentation of negative 575 
control)]. The data represent the means of three replicates; vertical bars 576 
represent standard deviations. 577 
 578 
Figure 5. Determination of the cytolytic effect of tyramine (A) and histamine 579 
(B) on intestinal cells. HT29 cells were seeded in 96-well plates and after 20 580 
h of growth in different concentrations of the corresponding BA were added 581 
to each well incubated for 24 h. Necrosis was then measured via lactate 582 
dehydrogenase activity (LDH). The data represent the percentage of cells 583 
lysed by treatment with different concentrations of tyramine or histamine. The 584 
percentage of cells lysed was calculated as follows: 100 X [(492 nm 585 
absorbance of treated samples – absorbance of negative control) / 586 
(absorbance of positive control – absorbance of negative control)]. Data 587 
represent the means of three replicates; vertical bars represent standard 588 
deviations. 589 
590 
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